95 related articles for article (PubMed ID: 15182642)
1. [Expression and biological activities of TRAIL fusion protein gene].
Li J; Zheng Y; Chen H; Du L; Shu CL; Cheng Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):535-7. PubMed ID: 15182642
[TBL] [Abstract][Full Text] [Related]
2. [Expression of Trial in mammalian cell and its apoptosis activation in culture cells].
Yao YC; Wang XM; Hu YP
Yi Chuan Xue Bao; 2001 May; 28(5):482-6. PubMed ID: 11441662
[TBL] [Abstract][Full Text] [Related]
3. [Induction of apoptosis in various cancer cell lines by human soluble TRAIL expressed in Escherichia coli].
Zheng X; Guan X; Lin Z
Zhonghua Yi Xue Za Zhi; 2000 Mar; 80(3):190-2. PubMed ID: 11798756
[TBL] [Abstract][Full Text] [Related]
4. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets.
Crist SA; Elzey BD; Ludwig AT; Griffith TS; Staack JB; Lentz SR; Ratliff TL
Exp Hematol; 2004 Nov; 32(11):1073-81. PubMed ID: 15539085
[TBL] [Abstract][Full Text] [Related]
5. The secretable form of trimeric TRAIL, a potent inducer of apoptosis.
Kim MH; Billiar TR; Seol DW
Biochem Biophys Res Commun; 2004 Sep; 321(4):930-5. PubMed ID: 15358116
[TBL] [Abstract][Full Text] [Related]
6. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
[TBL] [Abstract][Full Text] [Related]
7. Enhanced TRAIL sensitivity by E1A expression in human cancer and normal cell lines: inhibition by adenovirus E1B19K and E3 proteins.
Hu B; Zhu H; Qiu S; Su Y; Ling W; Xiao W; Qi Y
Biochem Biophys Res Commun; 2004 Dec; 325(4):1153-62. PubMed ID: 15555548
[TBL] [Abstract][Full Text] [Related]
8. [Cloning of human TRAIL cDNA and its expression in COS-7 cells].
Liu MM; Sa QL; Hu ZY; Qian HN; Yu YT; He FC
Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):113-5. PubMed ID: 10883290
[TBL] [Abstract][Full Text] [Related]
9. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
10. Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
Wenger T; Mattern J; Penzel R; Gassler N; Haas TL; Sprick MR; Walczak H; Krammer PH; Debatin KM; Herr I
Cell Death Differ; 2006 Oct; 13(10):1740-51. PubMed ID: 16470224
[TBL] [Abstract][Full Text] [Related]
11. [Cloning, expression and purification of human TNF-related apoptosis-inducing ligand in Escherichia coli].
Yao GH; Luan JF; Ye D; Lei QH; Zhu PY; Jin J; Hou YY
Wei Sheng Yan Jiu; 2006 Nov; 35(6):697-700. PubMed ID: 17290744
[TBL] [Abstract][Full Text] [Related]
12. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
[TBL] [Abstract][Full Text] [Related]
13. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
[TBL] [Abstract][Full Text] [Related]
14. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
15. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism].
Tang YX; Chen Y; Gu JF; Qi R; Zou WG; Jiang LL; Liu XY
Ai Zheng; 2005 May; 24(5):536-42. PubMed ID: 15890093
[TBL] [Abstract][Full Text] [Related]
16. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T
Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718
[TBL] [Abstract][Full Text] [Related]
17. Influence of expressed TRAIL on biophysical properties of the human leukemic cell line Jurkat.
Chen K; Li D; Jiang YH; Yao WJ; Wang XJ; Wei XC; Gao J; Xie LD; Yan ZY; Wen ZY; Chien S
Cell Res; 2004 Apr; 14(2):161-8. PubMed ID: 15115618
[TBL] [Abstract][Full Text] [Related]
18. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.
Sanlioglu AD; Koksal IT; Karacay B; Baykara M; Luleci G; Sanlioglu S
Cancer Gene Ther; 2006 Jan; 13(1):21-31. PubMed ID: 16052230
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
